Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA note was added clarifying that PubMed-listed publications are automatically filled from PubMed and may not relate to the study, along with an update to the revision tag v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoval of a government funding and operating status banner from the page. This does not alter the study details, eligibility criteria, locations, or outcomes.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant changes detected between the old and new screenshots; the Study Details page content and structure remain the same.SummaryDifference0.3%

- Check71 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference4%

- Check78 days agoChange DetectedNames/terms updated: 'Anaplastic astrocytoma' -> 'Astrocytoma, anaplastic'; version bumped from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdated to revision v3.0.2; the 'Back to Top' link was removed. No core content or time-sensitive data appears affected.SummaryDifference0.2%

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.